Bristol-Myers Squibb financials
$63.88+1.62%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $48.19B | $48.30B | $45.01B | $46.16B | $46.38B | $42.52B | $26.14B | $22.56B | $20.78B | $19.43B |
| Gross profit | $34.26B | $34.33B | $34.31B | $36.02B | $36.45B | $30.75B | $18.07B | $16.09B | $14.76B | $14.46B |
| Gross margin | 71.1% | 71.1% | 76.2% | 78.0% | 78.6% | 72.3% | 69.1% | 71.3% | 71.1% | 74.4% |
| Operating income | $10.00B | -$7.49B | $7.28B | $8.29B | $7.38B | -$9.19B | $5.91B | $5.11B | $3.45B | $4.47B |
| Net income | $7.05B | -$8.95B | $8.03B | $6.33B | $6.99B | -$9.02B | $3.44B | $4.92B | $1.01B | $4.46B |
| Net margin | 14.6% | −18.5% | 17.8% | 13.7% | 15.1% | −21.2% | 13.2% | 21.8% | 4.8% | 22.9% |
| Diluted EPS | $3.46 | $-4.41 | $3.86 | $2.95 | $3.12 | $-3.99 | $2.01 | $3.01 | $0.61 | $2.65 |
| EBITDA | $14.01B | $2.11B | $17.04B | $18.57B | $18.06B | $1.20B | $7.66B | $5.75B | $4.24B | $4.85B |
| Operating cash flow | $14.16B | $15.19B | $13.86B | $13.07B | $16.21B | $14.05B | $8.21B | $7.07B | $5.28B | $3.06B |
| Free cash flow | $12.85B | $13.94B | $12.65B | $11.95B | $15.23B | $13.30B | $7.37B | $6.12B | $4.22B | $1.84B |
| Diluted shares | 2,039.0M | 2,027.0M | 2,078.0M | 2,146.0M | 2,245.0M | 2,258.0M | 1,712.0M | 1,637.0M | 1,652.0M | 1,680.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $10.21B | $10.35B | $11.46B | $9.12B | $13.98B | $14.55B |
| Short-term investments | $464.0M | $513.0M | $816.0M | $130.0M | $2.99B | $1.28B |
| Total debt | $45.11B | $49.65B | $39.77B | $39.32B | $44.55B | $50.68B |
| Total assets | $90.04B | $92.60B | $95.16B | $96.82B | $109.31B | $118.48B |
| Total liabilities | $71.53B | $76.22B | $65.67B | $65.70B | $73.31B | $80.60B |
| Shareholders' equity | $18.51B | $16.39B | $29.48B | $31.12B | $36.01B | $37.88B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology